Why is Bliss GVS Pharma falling/rising?

As of 25-Jun, Bliss GVS Pharma Ltd's stock price is currently at 149.35, reflecting an increase of 1.35 or 0.91%. Despite opening the day with a loss of 2.03%, the stock managed to touch an intraday high of Rs 151.65, indicating some recovery during the trading session. Over the past week, the stock has shown a strong performance with a return of 6.75%, and it has outperformed the benchmark Sensex, which only gained 1.61% in the same period. However, it is worth noting that the stock's delivery volume has decreased by 17.71% compared to the 5-day average, suggesting a decline in investor participation. Additionally, while the stock has generated a substantial return of 44.23% over the past year, its profits have fallen by 19.5%, which may raise concerns among investors.
In the broader market context, Bliss GVS Pharma's recent performance has been impressive compared to the benchmark, particularly over the short term, where it has outperformed the Sensex significantly. The stock's long-term performance is also noteworthy, as it has outperformed the BSE 500 over the last three years, one year, and three months. The company's low debt-to-equity ratio and attractive valuation with a price-to-book value of 1.5 contribute positively to its market perception. However, the decline in profits could temper enthusiasm, even as the stock remains liquid enough for trading. Overall, while the stock is experiencing a rise today, the mixed signals regarding profitability and investor participation may influence future movements.